Respiratory Pharmacology Flashcards
1
Q
Smooth muscle contraction
A
- Ca2+ increase extracellular & sarcoplasmic reticulum
- Ca2+ binds to calmodulin
- Ca2+ and calmodulin complex activates myosin light chain kinase which phosphorylates myosin complex
- Myosin head can bind to actin
- Fibres contract by power stroke always smll level of contraction
2
Q
Parasympathetic innervation
A
- Parasmpathetic dominant by vagal nerve
- M1, M2 and (M3 which is most important)
- M3 produce most stimulatory effects from neurotransmitter acetylcholine
- Gq protien bind to M3 inosital phosphate pathway (increase IP3)
- Gland secreation calcium and smooth muscle of airways contraction
3
Q
Sympathetic NS Innervation
A
- Sympathetic innervate blood vessels and gland in trachea and blood vessel
- B2 adenoreceptors couple with apha subunit Gs smooth airway muscles and alveoli
- Increase in cAMP and PKA
- Inactivates myosin light chain kinase so myosin is not phosphorylated
- Respond to circling agonist - relax bronchial smooth muscle
- Activate potassium channel leaves hyperpolarise less likely to form AP
4
Q
Beta-adenoreceptors
A
- Mast cells inhibit mediator release
- Epithelium enhance muco-cilliary clearance
- Decrease in calcium
- Stimulation effects the heart, lungs, skeletal muscle and blood vessels
5
Q
Other forms of innervation
A
- Airways supplied with excitatory and inhibitory non-adrenergic non-cholinergic (NANC)
6
Q
What substance is secreted during broncoconstriction?
A
- Acytylcholine and substance P
7
Q
What substance is secreated during bronchodialation?
A
- Nitric oxide by the endothelial cells
8
Q
Receptors on bronchial smooth muscle
A
- Histamine for bronchoconstriction
- Leukotreines which are inflammatrory mediators for bronchoconstriction
9
Q
Aim of Bronchodialators
A
- Relief and rescuing patient from bronchospasm
10
Q
Aim of anti-inflammatories
A
- Prophylaxis by reducing frequency of attack
- Reduced severity of attacks
- Limit structure remodelling
11
Q
Bronchodialator classes
A
- Beta adenoceptor agonist
- Xanthines
- Muscarinic receptor agonist
- Leukotriene receptor antagonists
- Histamine receptor antagonists
12
Q
Anti-inflammatory receptor classes
A
- Glucocorticoids
- Cromoglicate and nedocromil
- Anti-IgE immunotherapy
- Phosphodiesterase (PDE) inhibitors
13
Q
Beta-adrenoceptor agonist mechanism
A
- Beta receptor stimulation via G protien activating adenylyl cyclase
- Increasing levels of cAMP activating protien kinase A which phosphorylates targets and leads to bronchodialation
- MLCK activity decrease less contract
- Activate K+ channel leads to hyperpolarisation decrease Ca2+ channel open less entry to intracellular so less contract
14
Q
Beta-adenoreceptor agonist
A
- Bronchodilation
- Inhibition of mediator release from mast cells
- Enhanced mucocilliary clearance
- Little effect on bronchochiral hyperactivity
15
Q
Delivery of Beta-adenoreceptor agonist
A
- Inhalation of aerosol powder or nebulised solution
- Lower dose required via airways fast onset of action with inhaled brochodialators than systemic